| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News + Adhoc | Bilanz/GuV | Termine | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Dividende/HV | Profil | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Vergleich | Insidertrades | Knock-outs | myHome |
| Orderbuch | Realtime Stuttgart | RSS Feed | im Forum | Fonds | Senden | |
| Historisch | Realtime Push | myNews neu | Ausblick | IR-Daten | Anleihen | handeln |
| Analyst | Buy | Hold | Sell | Kursziel* | Abstand | Datum |
|---|---|---|---|---|---|---|
| Close Brothers Seydler Research AG | 70,00€ | +5,90% | 24.04.12 | |||
| Independent Research GmbH | 70,00€ | +5,90% | 19.04.12 | |||
| Hanseatischer Börsendienst | 72,00€ | +8,93% | 17.02.12 | |||
| Euro am Sonntag | - | - | 06.02.12 | |||
| Hamburger Sparkasse AG (Haspa) | - | - | 02.02.12 | |||
| Deutsche Bank AG | 62,50CHF | - | 06.09.11 |
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 3 | 1 | 1 | 60,00 $ | -3,01% |
| Agennix AG | 0 | 1 | 0 | 2,00 € | +19,05% |
| Amgen Inc. | 5 | 10 | 1 | 72,09 $ | +3,31% |
| Bayer | 15 | 12 | 0 | 61,22 € | +19,78% |
| BB Biotech AG | 5 | 0 | 1 | 70,67 € | +6,91% |
| Biogen Idec Inc. | 9 | 2 | 0 | 139,20 $ | +6,03% |
| Biotest AG | 0 | 0 | 0 | - | - |
| Evotec AG | 3 | 0 | 0 | 3,75 € | +87,50% |
| Gilead Sciences Inc. | 10 | 1 | 0 | 58,80 $ | +16,04% |
| Merck KGaA | 4 | 17 | 1 | 81,56 € | +9,80% |
| MorphoSys AG | 3 | 3 | 0 | 22,98 € | +35,34% |
| QIAGEN N.V. | 8 | 7 | 2 | 13,50 € | +3,53% |
| UCB S.A. | 0 | 2 | 0 | 33,00 € | -15,19% |